Site name unknown, Los Angeles, CA

Site:	Site name unknown, Los Angeles, CA
Address:
City:	Los Angeles
State:	CA
Zip:
Country:	USA

Phase [asc]	Trial	Trial Status	Site Status	Drug	NCT#
1	Phase 1 Study of BIIB022 (Anti-IGF-1R Monoclonal Antibody) in Relapsed/Refractory Solid Tumors	Ongoing, but not recruiting	Closed	BIIB022	NCT00555724
1	Administration of BIIB028 to Subjects With Solid Tumors	Ongoing, but not recruiting	Closed	BIIB028	NCT00725933
2	AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors	Ongoing, but not recruiting	Closed	AMG 479 + AMG 655	NCT00819169